Cytori Therapeutics (CYTX) said the FDA approved its aesthetic body contouring device - PureGraft. The product will be available in the first quarter, but will be formally launched in May this year at the American Society of Aesthetic Plastic Surgeons, which estimates that over 46,000 fat grafting procedures were performed in the U.S. in 2008.
The device allows a patient's own fat tissue to be rapidly prepared in about 15 minutes for re-injection back into the same patient for aesthetic contouring and allows for cleaner grafting of the fat in less time than traditional methods.
The PureGraft will be sold in the U.S. directly by the company, as well as through select distribution partners on a non-exclusive basis.
Cytori is also seeking marketing approval for PureGraft in Europe, which is expected in the first half of 2010. In Europe, PureGraft will be sold as a standalone product as well as to complement Cytori's currently available autologous tissue processing system, the company noted.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.